Analyst Coverage Ajay Tandon SeeThruEquity www.seethruequity.com (646) 495-0939 firstname.lastname@example.org Please note that any opinions, estimates or forecasts regarding Zomedica’s performance made by these analysts are theirs alone and do not represent the opinions, estimates or forecasts of Zomedica or its management. Zomedica does not by its reference above or by distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. By your uses of this website, you agree that you must evaluate and bear all risks associated with the use of any third-party content, including any reliance on the accuracy and completeness of such content. Except for historical information, some of the statements set forth in the analysts’ reports constitute forward-looking statements regarding future events or the future financial performance of Zomedica. Words such as “expects,” “goals,” “plans,” “believes,” “may,” and variations of such words and similar expressions identify forward-looking statements. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially, as discussed in Zomedica’s filings disclosed under its profile on SEDAR at www.sedar.com.